patients carry fewer than 11 repeats (Lunt, 1998 the possibility that 4q35 genes proximal to D4Z4 play a role in disease initiation or progression. 
Introduction the result of a classical mutation within a protein-coding gene. We have previously reported that in FSHD muscle Facioscapulohumeral muscular dystrophy (FSHD) is the third most common inherited myopathy, with an incimany genes are transcriptionally misregulated, raising the possibility that a regulatory defect might be the undence of 1:20,000 (Padberg, 1982) . The disease is characterized by progressive weakness and atrophy of the derlying basis of disease (Tupler et al., 1999). Here we investigate the possibility that deletion of D4Z4 repeats facial and shoulder girdle muscles, which subsequently spreads to the abdominal and pelvic girdle muscles with initiates transcriptional misregulation. highly variable expression. The genetic defect follows autosomal dominant inheritance, although new mutaResults tions account for approximately 10% of recognized cases (Lunt, 1998) .
Inappropriate Overexpression of 4q35 Genes The FSHD locus was mapped to the subtelomeric in FSHD Dystrophic Muscle region of the long arm of chromosome 4, 4q35, by geTo investigate whether altered expression of 4q35 genes netic linkage analysis (Sarfarazi et al., 1992) . Almost all could be the underlying basis of FSHD, we collected FSHD patients carry rearrangements occurring in a 3.3 human muscle samples from normal individuals and pakilobase (kb) tandemly repeated sequence (D4Z4) lotients affected by FSHD as well as several other muscucated at the 4q subtelomeric region (Wijmenga et al., lar dystrophies including Duchenne muscular dystrophy 1992). These rearrangements result in EcoRI alleles (DMD), amyotrophic lateral sclerosis (ALS), and limb girshorter than 35 kb, providing the molecular marker for dle muscular dystrophy type 2 (LGMD). Expression of FSHD diagnosis (Lunt, 1998) . three 4q35 genes, FSHD region gene 1 (FRG1), FSHD D4Z4 is highly polymorphic with a variable number region gene 2 (FRG2), and the adenine nucleotide transtandem repeat (VNTR) structure (Hewitt et al., 1994; Wilocator-1 gene (ANT1), was analyzed by RT-PCR. nokur et al., 1994). In the general population, its size Figure 1A shows that expression of FRG2, the gene may vary between 11 and 150 units, whereas FSHD most proximal to D4Z4, was undetectable in normal muscle but was present at a significant level in all three FSHD muscle samples. Expression of the two other 4q35 genes, FRG1 and ANT1, was detected in all muscle samples but overexpressed only in FSHD muscle. Quantitation by phosphoimager analysis revealed, first, that in normal muscle the expression level of 4q35 genes increased with distance from D4Z4 and, second, that in FSHD muscle the level of overexpression varied inversely with distance from D4Z4. Glyceraldehyde Phosphate Dehydrogenase (GAPDH), which is not at 4q35, was expressed equivalently in all muscle samples. Significantly, Figure 1B shows that in lymphocytes from FSHD patients, expression of FRG2, FRG1, and ANT1 was equivalent to that observed in normal tissue, indicating that overexpression of 4q35 genes in FSHD is muscle specific. Expression of 4q35 genes was also normal in DMD, ALS, and LGMD muscle samples ( Figure  1C ), indicating that misregulated 4q35 gene expression is not a general characteristic of muscular dystrophies. As described above, the number of D4Z4 repeats is a critical determinant of disease severity (Ricci et al., 1999) . The results of Figures 1A-1C raised the possibility that inappropriate overexpression of 4q35 genes located upstream of D4Z4 was the underlying basis of FSHD. A prediction of this model is that 4q35 gene overexpression would be increased when the number of D4Z4 repeats is decreased. To test this prediction, we analyzed expression of FRG2 in muscle biopsies from six additional FSHD patients carrying varying numbers of D4Z4 repeats. The results of Figure 1D clearly demonstrate that the level of FRG2 overexpression is indeed inversely related to the number of D4Z4 repeats. On the basis of Figures 1A-1D , we conclude that 4q35 gene mRNAs and presumably proteins are overexpressed in FSHD muscle in a manner inversely related to distance from D4Z4 and the number of D4Z4 repeats.
Detection of a Nuclear Activity that Binds to D4Z4
The most likely mechanism by which D4Z4 could suppress 4q35 gene transcription is through interaction with a cellular factor (or factors) that silences the expression of nearby genes. We tested this possibility by analyzing the interaction between D4Z4 and nuclear proteins using an electrophoretic mobility shift assay (EMSA). Probes were generated by 32 P-end-labeling eight restriction enzyme-digested fragments that spanned the entire D4Z4 from HeLa cells, C2C12 myoblasts, or C2C12 myotubes, of G418-resistant colonies decreased by 25%, 45%, and 86%, respectively. Significantly, insertion of a nonrea 27 basepair (bp) sequence (CCATTCATGAAGGGGTG GAGCCTGCCT) within D4Z4-243 was protected from lated spacer sequence had no effect, indicating that the decrease in colony number was not simply due to DNase I digestion. We will refer to this 27 bp sequence as the D4Z4 binding element (DBE).
increased distance between the CMV promoter and the reporter gene. On the basis of these results, we conclude that the DBE within D4Z4 is a transcriptional repression The DBE Is a Transcriptional Repression Element One explanation for the results presented above is that element. the DBE is a transcriptional repression element that, when deleted in FSHD, leads to overexpression of 4q35
Identification of a Multiprotein Complex that Binds to the DBE genes. To test this hypothesis, we analyzed the ability of the DBE to suppress transcription of a reporter gene To identify and characterize proteins that bind to the DBE, we biochemically purified the D4Z4 recognition expressed from the strong cytomegalovirus (CMV) promoter. Analogous assays have been used previously to complex (DRC) using sequential chromatography of HeLa nuclear extracts on P11 Phosphocellulose, DEAEidentify positive and negative transcriptional regulatory elements (see, for example, Chung et al., 1997).
Sepharose, and DBE-Agarose (see Figure 4A , schematic). The purified DRC was fractionated on an SDSWe constructed a series of plasmids in which increasing numbers of DBEs were inserted between the CMV PAGE gel, and the polypeptides were detected by silver staining, excised, and microsequenced by mass specpromoter and the neomycin-resistance gene. The plasmids were stably transfected into HeLa cells, and the trometry. Figure 4A shows that four bands were present in the active fraction: YY1, a multifunctional repressor/ number of G418-resistant colonies was quantitated. As shown in Figure 3, Figure 5A shows that all three DRC components, YY1, HMGB2, and nucleolin, were associated with D4Z4 sequences. In contrast, there was no detectable binding of any DRC component to the control sequences p13E-11 or FRG1. The human genome contains sequences homologous to D4Z4 on several chromosomes in addition to 4 (Wij- 
Reducing the Levels of DRC Components Results

To verify that this multiprotein complex was in fact the in Overexpression of 4q35 Genes nuclear DBE binding activity, mobility-shift experiments
The results presented above suggest that deletion of were performed using antibodies directed against YY1, D4Z4 repeats reduces the number of DBEs and thus the HMGB2, and nucleolin. Figure 4B shows that antibodies number of DNA bound DRCs present at 4q35. Reducing to nucleolin and HMGB2 resulted in formation of a lower the number of bound transcriptional repressing commobility complex ("supershift"), whereas addition of a plexes is predicted to result in the inappropriate upregucontrol antibody had no effect. An antibody to YY1 interlation of 4q35 genes. To verify that the DRC is responsifered with formation of the DBE mobility shift, sugble for the lack of 4q35 gene expression in normal cells, gesting that association of YY1 with either a component we performed antisense experiments to decrease the of the DRC or the DBE itself had been disrupted. intracellular levels of DRC components.
HeLa cells were transfected with morpholino oligonuRecognition of the DBE by YY1
cleotides targeted to human YY1, HMGB2, or nucleolin We noticed that the DBE contains a putative YY1 recogmRNA. The immunoblot in Figure 6A shows that each nition sequence (CCATN; Yant et al., 1995), suggesting antisense oligonucleotide specifically reduced the level that YY1 directly interacts with the DBE. To test this of its cognate protein. Figure 6B shows that reducing possibility, we carried out mobility-shift experiments usthe levels of YY1, HMGB2, or nucleolin resulted in overing recombinant YY1. Figure 4C shows that recombinant expression of the 4q35 gene FRG2. Thus, reducing the GST-YY1, but not GST alone, bound the DBE probe. A levels of DRC components recapitulates the molecular DBE probe containing a mutation within the YY1 core event observed at 4q35 in FSHD muscle. recognition sequence was not bound by GST-YY1. Moreover, this mutant probe failed to support a mobility shift with HeLa nuclear extract ( Figure 4C, right) , sugDiscussion gesting that elimination of YY1 binding also abolished association of the entire DRC to the DBE. We conclude A Model for the Molecular Basis of FSHD FSHD is a complex disease with a peculiar involvement that YY1 has an intrinsic DBE binding activity and that YY1 is the most likely DRC component to directly conof muscle groups, highly variable severity, and unpredictable progression. The disease has been causally tact the DBE. related to deletion of subtelomeric D4Z4 repeats at 4q35; however, no candidate gene has been isolated. The DRC Binds D4Z4 In Vivo To determine whether the DRC also binds D4Z4 seThe failure to identify an expressed sequence in this region has prompted an alternative model that proposes quences in vivo, we performed chromatin immunoprecipitation (ChIP) experiments. HeLa cells were first the disease is due to the inappropriate expression of nearby genes by a positional effect. According to this treated with formaldehyde to induce crosslinks between Based on the results presented in this study, we prothe autosomal dominant transmission of FSHD. Our finding that 4q35 gene overexpression is muscle specific pose a different model for the molecular basis of FSHD (Figure 7) . In normal individuals, the presence of a ( Figure 1B ) also provides an attractive explanation for the tissue specificity of the disease. However, it is importhreshold number of D4Z4 repeats leads to repression of 4q35 genes by virtue of a DNA bound multiprotein tant to recognize that FSHD is a complex disorder, and in addition to overexpression of 4q35 genes, factors complex that actively suppresses gene expression. In FSHD patients, deletion of an integral number of D4Z4 such as the allelic variability of 4q35 genes, gender, and environment may also affect disease onset and severity. repeats reduces the number of bound repressor complexes and consequently decreases (or abolishes) tranThe precise basis by which overexpression of 4q35 genes results in FSHD remains to be determined. Descriptional repression of 4q35 genes. As a result, these genes are inappropriately overexpressed, ultimately tailed analysis of the sequence surrounding the D4Z4 repeats has revealed it to be a relatively gene-poor releading to disease onset and progression. We have shown that the extent of transcriptional derepression is gion with a high density of pseudogenes and repetitive to be mediated through interactions with corepressors 
such as histone deacetylases (Thomas and Seto, 1999). A second noteworthy similarity is that repression varies as a function of chromosome position. Yeast telo-HMGB2 is a member of a family of nonhistone nuclear proteins that modulate chromatin architecture (Thomas meric silencing is initiated at the chromosome terminus and, in general, decreases as a function of distance from and Travers, 2001). Interestingly, HMGB2 has previously been shown to interact with two other proteins, SP100 the telomere (Renauld et al., 1993). Similarly, we have found a relationship between the distance of the gene and HP1, to form a transcriptional repressing complex (Lehming et al., 1998). Nucleolin has been shown to be from the 4q telomere and transcriptional repression (Fig
